Stockreport

Aerie Pharmaceuticals Reports Topline Result from Rhopressa® Mechanism of Action Study

Aerie Pharmaceuticals, Inc.  (AERI) 
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aeriepharma.com/investor-relations
PDF Clinical confirmation of the effect of Rhopressa® on trabecular meshwork outflow facility in patients with open-angle glaucoma or ocular hypertension [Read more]